Jundishapur Journal of Microbiology

Published by: Kowsar

Tosufloxacin for Eradicating Biofilm-Forming Nontypeable Haemophilus influenzae Isolated from Intractable Acute Otitis Media

Masanobu Hiraoka 1 , Gen Sugita 1 , Mehmet Gunduz 1 , Esra Gunduz 1 , Shunji Tamagawa 1 , Masamitsu Kono 1 , Saori Takeda 1 , Noboru Yamanaka 1 , 2 and Muneki Hotomi 1 , *
Authors Information
1 Department of Otorhinolaryngology-Head and Neck Surgery, Wakayama Medical University, Wakayama, Japan
2 Department of Otorhinolaryngology, Goshomi Hospital, Kanagawa, Japan
Article information
  • Jundishapur Journal of Microbiology: 12 (3); e69583
  • Published Online: February 20, 2019
  • Article Type: Research Article
  • Received: April 19, 2018
  • Revised: January 14, 2019
  • Accepted: January 30, 2019
  • DOI: 10.5812/jjm.69583

To Cite: Hiraoka M, Sugita G, Gunduz M, Gunduz E, Tamagawa S, et al. Tosufloxacin for Eradicating Biofilm-Forming Nontypeable Haemophilus influenzae Isolated from Intractable Acute Otitis Media, Jundishapur J Microbiol. Online ahead of Print ; 12(3):e69583. doi: 10.5812/jjm.69583.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Xu Q, Kaur R, Casey JR, Adlowitz DG, Pichichero ME, Zeng M. Identification of Streptococcus pneumoniae and Haemophilus influenzae in culture-negative middle ear fluids from children with acute otitis media by combination of multiplex PCR and multi-locus sequencing typing. Int J Pediatr Otorhinolaryngol. 2011;75(2):239-44. doi: 10.1016/j.ijporl.2010.11.008. [PubMed: 21126776]. [PubMed Central: PMC3563323].
  • 2. Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2009;28(1):43-8. doi: 10.1097/INF.0b013e318184dba2. [PubMed: 19057458].
  • 3. Barkai G, Leibovitz E, Givon-Lavi N, Dagan R. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J. 2009;28(6):466-71. doi: 10.1097/INF.0b013e3181950c74. [PubMed: 19504729].
  • 4. Yano H, Yamazaki Y, Qin L, Okitsu N, Yahara K, Irimada M, et al. Improvement rate of acute otitis media caused by Haemophilus influenzae at 1 week is significantly associated with time to recovery. J Clin Microbiol. 2013;51(11):3542-6. doi: 10.1128/JCM.01108-13. [PubMed: 23966504]. [PubMed Central: PMC3889731].
  • 5. Anderson GG, O'Toole GA. Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol. 2008;322:85-105. doi: 10.1007/978-3-540-75418-3_5. [PubMed: 18453273].
  • 6. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002;8(9):881-90. doi: 10.3201/eid0809.020063. [PubMed: 12194761]. [PubMed Central: PMC2732559].
  • 7. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167-93. doi: 10.1128/CMR.15.2.167-193.2002. [PubMed: 11932229]. [PubMed Central: PMC118068].
  • 8. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358(9276):135-8. doi: 10.1016/S0140-6736(01)05321-1. [PubMed: 11463434].
  • 9. Osman KL, Jefferies JM, Woelk CH, Cleary DW, Clarke SC. The adhesins of non-typeable Haemophilus influenzae. Expert Rev Anti Infect Ther. 2018;16(3):187-96. doi: 10.1080/14787210.2018.1438263. [PubMed: 29415569].
  • 10. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol. 1995;49:711-45. doi: 10.1146/annurev.mi.49.100195.003431. [PubMed: 8561477].
  • 11. Sandai D, Tabana YM, Ouweini AE, Ayodeji IO. Resistance of Candida albicans biofilms to drugs and the host immune system. Jundishapur J Microbiol. 2016;9(11). e37385. doi: 10.5812/jjm.37385. [PubMed: 28138373]. [PubMed Central: PMC5240163].
  • 12. Ghanbarzadeh Corehtash Z, Khorshidi A, Firoozeh F, Akbari H, Mahmoudi Aznaveh A. Biofilm formation and virulence factors among Pseudomonas aeruginosa isolated from burn patients. Jundishapur J Microbiol. 2015;8(10). e22345. doi: 10.5812/jjm.22345. [PubMed: 26587205]. [PubMed Central: PMC4644346].
  • 13. Heydari S, Eftekhar F. Biofilm formation and beta-lactamase production in burn isolates of Pseudomonas aeruginosa. Jundishapur J Microbiol. 2015;8(3). e15514. doi: 10.5812/jjm.15514. [PubMed: 25964848]. [PubMed Central: PMC4417555].
  • 14. Starner TD, Zhang N, Kim G, Apicella MA, McCray PJ. Haemophilus influenzae forms biofilms on airway epithelia: Implications in cystic fibrosis. Am J Respir Crit Care Med. 2006;174(2):213-20. doi: 10.1164/rccm.200509-1459OC. [PubMed: 16675778]. [PubMed Central: PMC2662906].
  • 15. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284(5418):1318-22. doi: 10.1126/science.284.5418.1318. [PubMed: 10334980].
  • 16. Murphy TF, Kirkham C. Biofilm formation by nontypeable Haemophilus influenzae: Strain variability, outer membrane antigen expression and role of pili. BMC Microbiol. 2002;2:7. doi: 10.1186/1471-2180-2-7. [PubMed: 11960553]. [PubMed Central: PMC113772].
  • 17. Duell BL, Su YC, Riesbeck K. Host-pathogen interactions of nontypeable Haemophilus influenzae: From commensal to pathogen. FEBS Lett. 2016;590(21):3840-53. doi: 10.1002/1873-3468.12351. [PubMed: 27508518].
  • 18. Torretta S, Marchisio P, Drago L, Baggi E, De Vecchi E, Garavello W, et al. Nasopharyngeal biofilm-producing otopathogens in children with nonsevere recurrent acute otitis media. Otolaryngol Head Neck Surg. 2012;146(6):991-6. doi: 10.1177/0194599812438169. [PubMed: 22357644].
  • 19. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296(2):202-11. doi: 10.1001/jama.296.2.202. [PubMed: 16835426]. [PubMed Central: PMC1885379].
  • 20. Moriyama S, Hotomi M, Shimada J, Billal DS, Fujihara K, Yamanaka N. Formation of biofilm by Haemophilus influenzae isolated from pediatric intractable otitis media. Auris Nasus Larynx. 2009;36(5):525-31. doi: 10.1016/j.anl.2008.10.010. [PubMed: 19135325].
  • 21. Kaji C, Watanabe K, Apicella MA, Watanabe H. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med. 2008;214(2):121-8. doi: 10.1620/tjem.214.121. [PubMed: 18285669].
  • 22. Qin L, Kida Y, Ishiwada N, Ohkusu K, Kaji C, Sakai Y, et al. The relationship between biofilm formations and capsule in Haemophilus influenzae. J Infect Chemother. 2014;20(3):151-6. doi: 10.1016/j.jiac.2013.06.001. [PubMed: 24560562].
  • 23. Uemura Y, Qin L, Gotoh K, Ohta K, Nakamura K, Watanabe H. Comparison study of single and concurrent administrations of carbapenem, new quinolone, and macrolide against in vitro nontypeable Haemophilus influenzae mature biofilms. J Infect Chemother. 2013;19(5):902-8. doi: 10.1007/s10156-013-0598-5. [PubMed: 23605250].
  • 24. Slinger R, Chan F, Ferris W, Yeung SW, St Denis M, Gaboury I, et al. Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms. Diagn Microbiol Infect Dis. 2006;56(3):247-53. doi: 10.1016/j.diagmicrobio.2006.04.012. [PubMed: 16769194].
  • 25. Takei S, Hotomi M, Yamanaka N. Minimal biofilm eradication concentration of antimicrobial agents against nontypeable Haemophilus influenzae isolated from middle ear fluids of intractable acute otitis media. J Infect Chemother. 2013;19(3):504-9. doi: 10.1007/s10156-013-0592-y. [PubMed: 23549738].
  • 26. Hoberman A, Paradise JL, Rockette HE, Kearney DH, Bhatnagar S, Shope TR, et al. Shortened antimicrobial treatment for acute otitis media in young children. N Engl J Med. 2016;375(25):2446-56. doi: 10.1056/NEJMoa1606043. [PubMed: 28002709]. [PubMed Central: PMC5319589].
  • 27. Hoberman A, Paradise JL, Rockette HE, Shaikh N, Wald ER, Kearney DH, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364(2):105-15. doi: 10.1056/NEJMoa0912254. [PubMed: 21226576]. [PubMed Central: PMC3042231].
  • 28. Tahtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med. 2011;364(2):116-26. doi: 10.1056/NEJMoa1007174. [PubMed: 21226577].
  • 29. Kitamura K, Iino Y, Kamide Y, Kudo F, Nakayama T, Suzuki K, et al. Clinical practice guidelines for the diagnosis and management of acute otitis media (AOM) in children in Japan - 2013 update. Auris Nasus Larynx. 2015;42(2):99-106. doi: 10.1016/j.anl.2014.09.006. [PubMed: 25450605].
  • 30. Smith A, Buchinsky FJ, Post JC. Eradicating chronic ear, nose, and throat infections: A systematically conducted literature review of advances in biofilm treatment. Otolaryngol Head Neck Surg. 2011;144(3):338-47. doi: 10.1177/0194599810391620. [PubMed: 21493193].
  • 31. Yamanaka N, Hotomi N. Bactericidal effect of tosufloxacin on Haemophilus influenzae internalized in cultured human cells. Jpn J Antibiot. 2016;69(5):309-18. [PubMed: 30226944].
  • 32. Sugiura Y, Takahata M, Fukuda Y, Nomura N. [In vitro antibactericidal activity of tosufloxacin against non-typeable Haemophilus influenzae forming biofilm]. Jpn J Chemother. 2012;60(3):327-34. Japanese.
  • 33. Patel JB, Patel R, Weinstein MP, Richter SS, Eliopoulos GM, Satlin M, et al. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100-S17. 27th ed. Wayne: Clinical and Laboratory Standard Institute; 2007.
  • 34. Hoa M, Tomovic S, Nistico L, Hall-Stoodley L, Stoodley P, Sachdeva L, et al. Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH. Int J Pediatr Otorhinolaryngol. 2009;73(9):1242-8. doi: 10.1016/j.ijporl.2009.05.016. [PubMed: 19525016].
  • 35. Hong W, Juneau RA, Pang B, Swords WE. Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media. J Innate Immun. 2009;1(3):215-24. doi: 10.1159/000205937. [PubMed: 20375579].
  • 36. Post JC. Direct evidence of bacterial biofilms in otitis media. 2001. Laryngoscope. 2015;125(9):2003-14. doi: 10.1002/lary.25291. [PubMed: 26297170].
  • 37. Nistico L, Kreft R, Gieseke A, Coticchia JM, Burrows A, Khampang P, et al. Adenoid reservoir for pathogenic biofilm bacteria. J Clin Microbiol. 2011;49(4):1411-20. doi: 10.1128/JCM.00756-10. [PubMed: 21307211]. [PubMed Central: PMC3122793].
  • 38. Nistico L, Gieseke A, Stoodley P, Hall-Stoodley L, Kerschner JE, Ehrlich GD. Fluorescence "in situ" hybridization for the detection of biofilm in the middle ear and upper respiratory tract mucosa. Methods Mol Biol. 2009;493:191-213. doi: 10.1007/978-1-59745-523-7_12. [PubMed: 18839349].
  • 39. Wu S, Li X, Gunawardana M, Maguire K, Guerrero-Given D, Schaudinn C, et al. Beta- lactam antibiotics stimulate biofilm formation in non-typeable Haemophilus influenzae by up-regulating carbohydrate metabolism. PLoS One. 2014;9(7). e99204. doi: 10.1371/journal.pone.0099204. [PubMed: 25007395]. [PubMed Central: PMC4090067].
  • 40. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37(6):1771-6. [PubMed: 10325322]. [PubMed Central: PMC84946].
  • 41. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000;54:49-79. doi: 10.1146/annurev.micro.54.1.49. [PubMed: 11018124].
  • 42. Domenech M, Pedrero-Vega E, Prieto A, Garcia E. Evidence of the presence of nucleic acids and beta-glucan in the matrix of non-typeable Haemophilus influenzae in vitro biofilms. Sci Rep. 2016;6:36424. doi: 10.1038/srep36424. [PubMed: 27805043]. [PubMed Central: PMC5090351].
  • 43. Webster P, Wu S, Gomez G, Apicella M, Plaut AG, St Geme J3. Distribution of bacterial proteins in biofilms formed by non-typeable Haemophilus influenzae. J Histochem Cytochem. 2006;54(7):829-42. doi: 10.1369/jhc.6A6922.2006. [PubMed: 16549506].
  • 44. Neu T, Swerhone GD, Lawrence JR. Assessment of lectin-binding analysis for in situ detection of glycoconjugates in biofilm systems. Microbiology. 2001;147(Pt 2):299-313. doi: 10.1099/00221287-147-2-299. [PubMed: 11158347].
  • 45. Poulsen LK, Ballard G, Stahl DA. Use of rRNA fluorescence in situ hybridization for measuring the activity of single cells in young and established biofilms. Appl Environ Microbiol. 1993;59(5):1354-60. [PubMed: 7685999]. [PubMed Central: PMC182089].
  • 46. Hong W, Mason K, Jurcisek J, Novotny L, Bakaletz LO, Swords WE. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect Immun. 2007;75(2):958-65. doi: 10.1128/IAI.01691-06. [PubMed: 17130253]. [PubMed Central: PMC1828519].
  • 47. Hong W, Pang B, West-Barnette S, Swords WE. Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J Bacteriol. 2007;189(22):8300-7. doi: 10.1128/JB.00532-07. [PubMed: 17573475]. [PubMed Central: PMC2168690].
  • 48. Canafax DM, Yuan Z, Chonmaitree T, Deka K, Russlie HQ, Giebink GS. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr Infect Dis J. 1998;17(2):149-56. doi: 10.1097/00006454-199802000-00014. [PubMed: 9493813].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments